智通财经APP获悉，美国门诊影像诊断服务提供商Lumexa Imaging Holdings于周二公布了其首次公开募股(IPO)条款。该公司计划以每股17-20美元的价格发行2500万股股票，以筹资4.63亿美元。该公司计划在纳斯达克上市，股票代码为“LMRI”。
据悉，Lumexa Imaging总部位于北卡罗来纳州，是一家全国性的门诊诊断影像服务提供商，通过全资运营及与医疗系统合资合作的模式，在美国13个州运营着184家诊疗中心。该公司提供包括磁共振(MRI)、计算机断层扫描(CT)、正电子发射断层显像(PET)、X光、超声及乳房X光检查在内的各类先进及常规影像检查服务。该公司由Charlotte Radiology与投资机构Welsh, Carson, Anderson & Stowe于2018年联合创立，成立之初仅拥有20家中心，后通过20次收购及41家全新门店的开设实现规模扩张。目前，该公司已构建多元化转诊网络，合作医师覆盖2.9万余家医疗机构，总人数约10万名。数据显示，该公司在截至2025年9月30日的12个月销售额为10亿美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.